Voloridge Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
RCMNY
AIM
NAMA
B
Voloridge Investment Management's ADPT Position: Q1 2025 in Review
Voloridge Investment Management sold out of Adaptive Biotechnologies (ADPT) in Q1 2025, closing a stake of 29,093 shares — an estimated $174K sold.
Voloridge Investment Management first reported a position in ADPT in Q2 2020 and held it in 16 quarters. The position peaked at $13.2M in Q4 2020. 225 funds tracked by Wall St. Rank hold ADPT as of Q1 2025.
- Voloridge Investment Management reported no remaining Adaptive Biotechnologies position as of Q1 2025 after selling out during the quarter.
- Voloridge Investment Management sold 29,093 Adaptive Biotechnologies shares in Q1 2025, an estimated $174K.
- Voloridge Investment Management first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 16 quarters.
- Voloridge Investment Management's Adaptive Biotechnologies position peaked at $13.2M in Q4 2020.
- 225 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2025.
Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.